Avidity Biosciences
RNA
#2609
Rank
S$7.32 B
Marketcap
$61.94
Share price
-1.66%
Change (1 day)
733.63%
Change (1 year)

Avidity Biosciences (RNA) - Cash on Hand

Cash on Hand as of June 2024 : S$1.72 Billion

According to Avidity Biosciences's latest financial reports the company has S$1.72 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Avidity Biosciences - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.78 B-3.96%
2022-12-31S$0.81 B49.34%
2021-12-31S$0.54 B26.29%
2020-12-31S$0.43 B240.46%
2019-12-31S$0.12 B2920.52%
2018-12-31S$4.22 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$1.44 B-15.84%๐Ÿ‡บ๐Ÿ‡ธ USA
S$12.41 M-99.28%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.93 B 12.43%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.49 B-71.08%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.40 B-76.53%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.41 B 446.63%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.69 B 230.91%๐Ÿ‡ฌ๐Ÿ‡ง UK